A previous smaller pilot study consisting of 60 stroke patients has shown higher CT-pro-ET-1 levels associated with unfavorable outcome and mortality (5), whereas an older case-control study did not show a significant difference in CT-pro-ET-1 levels between healthy controls and ischemic stroke patients (21). The gene discussed is EDN1; the disease is stroke disorder.